- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Oncolytics Biotech Inc (ONCY)
Currency in USD
0.791
-0.048(-5.96%)
Closed
After Hours
0.800+0.009(+1.138%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.782
0.830
52 wk Range
0.710
1.530
TSX:ONCY Financials
Explore the TSX:ONC financials. Find the Oncolytics Biotech financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the Oncolytics Biotech annual report, the income statement, balance sheet, and cash flow statement. Gain deeper insights with financial ratios that assess the company's performance and stability. Users can customize their view by selecting data from four periods of either annual or quarterly information, making it easy to track the financial performance of Oncolytics Biotech over time.
Advanced Financial Summary
Key Ratios
Statements Highlights
| Period Ending: | 2014 31/12 | 2015 31/12 | 2016 31/12 | 2017 31/12 | 2018 31/12 | 2019 31/12 | 2020 31/12 | 2021 31/12 | 2022 31/12 | 2023 31/12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | - | - | - | |
Gross Profit | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | - | - | - | - | - | |
Operating Income | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -20.14 | -25.46 | -26.24 | -26.92 | -33.79 | |
Net Income | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -33.12 | -22.51 | -26.3 | -24.84 | -27.75 | |
Total Assets | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 19.66 | 34.35 | 45.88 | 37.33 | 38.82 | |
Total Current Liabilities | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 12.87 | 2.71 | 2.69 | 3.95 | 4.24 | |
Total Equity | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -0.11 | 24.75 | 36.1 | 26.5 | 27.56 | |
Levered Free Cash Flow | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -4.96 | -20.74 | -13.59 | -12.68 | -18 | |
Cash from Operations | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -19.91 | -22.07 | -22.43 | -23.36 | -28.45 | |
Cash from Investing | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | -0.01 | -0.03 | -0.29 | -20.4 | 20.22 | |
Cash from Financing | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 21.02 | 39.77 | 33.02 | 12.21 | 31.99 | |
Net Change in Cash | aa.aa | aa.aa | aa.aa | aa.aa | aa.aa | 0.45 | 17.07 | 10.04 | -29.6 | 23.25 | |
* In Millions of CAD (except for per share items)
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.